that italy fine on $META over android users' data access makes the rest of the world look like amateurs
153
Cash in the account hits different. Paper gains are just vibes until they clear.
#teenageers
$MSFT $TSLA
This quoted post is unavailable.
229
Reusing proven tech instead of burning fresh capital is exactly what I want to see. Watching that next filing too 👀
#teenageers
$NVDA $LUNR
This quoted post is unavailable.
899
Exactly this. Patience pays, most people just can't sit still long enough to let the setup come to them.
This quoted post is unavailable.
117
$NRED is up +55.56% over the past 5 days and closed another +7.69%.
The market is clearly reacting to the company’s shift toward MetalCore AI, mining robotics and automation.
Momentum is strong, and the mining-tech story keeps gaining attention.
1
1,833
$NRED pivoting to AI mining tech with MetalCore is a bold reset. Saitarli's computer vision background fits the automation push. Watching how this plays out.
#talkjustimg
$PLTR $SMCI
BREAKING: $NRED is rebuilding the story around AI mining tech
MetalCore, robotics and automation are moving to the center while new CEO Valentin Saitarli brings an AI and computer vision background
The company is clearly aiming for a broader mining-tech model
603
Yep, this is the pivot that actually matters. AI brain + mining robots is a way better story than another drill hole
#teenageee
$RXRX $GOLD
964
Healthcare AI going from $56B to $1T is the kind of math that makes the RYET move look tiny in hindsight. Planting the flag in Malaysia now is just step one.
#bb28
$JPM $JOBY
The bigger picture behind the latest $RYET news is much larger than one Malaysia agreement
AI in healthcare is becoming a global industry. Current market estimates put the sector at roughly $56B in 2026, with forecasts reaching around $1 TRILLION by 2034.
That is the market backdrop for RYET latest move.
Ruanyun announced a definitive agreement involving Cogni AI and BioNexus Gene Lab in Malaysia, giving its AI technology a path into healthcare rather than keeping it limited to education and enterprise applications.
The structure is interesting too: an exclusive license framework of up to 20 years, 10% royalty economics on qualifying technology receipts, and 560K BGLC shares at closing.
For me, this is what makes the news important.
RYET is not suddenly becoming a healthcare giant. It is testing whether Cogni AI can be licensed into a completely different industry and international market while that industry itself is experiencing massive AI adoption.
Education was the starting point.
Enterprise AI expanded the story.
Now healthcare adds another potential use case.
If Cogni AI can continue moving across industries and markets, that becomes a much more interesting business model than relying on one product or one sector.
Malaysia may be only the first healthcare test, but it puts RYET directly in front of one of the fastest-growing global technology trends.
324
Healthcare just entered the story: BioNexus is bringing Cogni AI into a new vertical is now part of the story. Cogni AI is moving into Malaysia healthcare through BioNexus, with an exclusive license for up to 20 years. Healthcare now joins the expansion story. $RYET
146
Rob McGill retweeted
Oct. 2: $NVDA closed at 233.95 with its Trend Score at 10.
Sentiment was 67.95, still below the 80 upper threshold, while 20-day historical volatility fell to 24.66, a six-month low.
Strong trend, sentiment below its upper zone, volatility compressed.
Get the data via SentimenTrader: sentimentrader.com/light-dat…















